Jimini Health, a New York–based company building clinician-supervised, patient-facing AI infrastructure for large behavioral health provider organizations, has raised $17 million in Seed funding.
Investors
The round was led by M13, with participation from Town Hall Ventures, LionBird, Zetta Venture Partners, and OneMind, bringing Jimini Health’s total funding to over $25 million.
M13 is an early-stage venture capital firm based in Santa Monica and New York. Founded in 2016, the firm focuses on seed and Series A investments in disruptive software businesses. M13 combines funding with a venture studio model, offering strategic guidance in areas such as product development, marketing, and customer acquisition.
Jimini Health Use of Funds
The company will use the funding to expand AI development across additional clinical settings and scale partnerships with large behavioral health providers nationwide.
About Jimini Health
Led by CEO Luis Voloch, Jimini Health is a healthcare technology company building clinician-supervised AI infrastructure for large behavioral health provider organizations. The platform enables providers to deploy AI safely, compliantly, and at scale, with licensed clinicians maintaining oversight of every patient interaction. Its core platform, Sage, supports the implementation of AI in clinical environments while adhering to regulatory requirements. Designed for regulated healthcare settings, Sage integrates directly with clinical organizations, enabling the industry to adopt AI effectively within existing care models.
Funding Details
Company: Jimini Health, Inc.
Raised: $17.0M
Round: Seed
Funding Date: April 2026
Lead Investor: M13
Additional Investors: Town Hall Ventures, LionBird, Zetta Venture Partners, OneMind
Company Website: https://jiminihealth.com/
Software Category: Healthcare AI / Behavioral Health Infrastructure
Source: Jimini Health